SCHEMBL13065607

SCHEMBL13065607

CCc1ccc(-c2c(C(=O)O)c3nc4ccc(N(C)C)cc4oc-3c(O)c2=O)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC16A3 O15427 1/20 0.36
SNCA P37840 1/20 0.35
MAPT P10636 3/20 0.35
POLB P06746 3/20 0.35
ELANE P08246 1/20 0.34
MEN1 O00255 1/20 0.33
NPC1 O15118 1/20 0.33
RAB9A P51151 1/20 0.33
KMT2A Q03164 1/20 0.33
GPR119 Q8TDV5 2/20 0.33
IKBKE Q14164 1/20 0.33
TBK1 Q9UHD2 1/20 0.33
DHODH Q02127 2/20 0.32
SCP2 P22307 1/20 0.32
LRP6 O75581 1/20 0.32
DKK1 O94907 1/20 0.32
CYP1A2 P05177 1/20 0.32
CYP2D6 P10635 1/20 0.32
CYP2C19 P33261 1/20 0.32
HIF1A Q16665 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13065598 0.92 MEN1 (0.43) SLC16A3MAPTPOLBMEN1NPC1
SCHEMBL16784717 0.90 DHODH (0.39) SLC16A3SNCAMAPTPOLBMEN1
SCHEMBL13065583 0.89 PSMB5 (0.40) SLC16A3MAPTPOLBMEN1NPC1
SCHEMBL13065585 0.86 SLC16A3 (0.38) SLC16A3SNCAMAPTGPR119IKBKE
SCHEMBL13065623 0.85 MEN1 (0.41) SLC16A3MAPTPOLBMEN1NPC1
SCHEMBL16784744 0.84 PDE10A (0.40) MAPTPOLBMEN1NPC1RAB9A
SCHEMBL13065622 0.83 MEN1 (0.43) SLC16A3MAPTPOLBMEN1NPC1
SCHEMBL13065601 0.83 KMT2A (0.43) SLC16A3MAPTPOLBMEN1NPC1
SCHEMBL13065605 0.83 MEN1 (0.43) SLC16A3MAPTPOLBMEN1NPC1
SCHEMBL13065591 0.83 MEN1 (0.49) SLC16A3MAPTPOLBMEN1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9052324-B2 Compounds and assays for controlling Wnt activity ENZO BIOCHEM, INC. (US) 2015-06-09 US disclosed
US-20120322717-A9 Compounds and assays for controlling Wnt activity ENZO BIOCHEM, INC. 2012-12-20 US disclosed
US-20100298200-A1 Compounds and assays for controlling Wnt activity LIU DAKAI 2010-11-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120322717-A9 Compounds and assays for controlling Wnt activity WNT1, WNT3A, WNT3 SLC16A3 4620/4885SNCA 3721/4885MAPT 3092/4885
US-20100298200-A1 Compounds and assays for controlling Wnt activity WNT1, WNT3A, WNT3 SLC16A3 4620/4885SNCA 3721/4885MAPT 3092/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.